Signs of angels come at the most unexpected — yet vital — moments in our lives, columnist Juliet Taylor writes.

The analyses offer evidence for a slowing of functional decline and improved survival outcomes with long-term Radicava ORS by ...

Taking short breaks from caregiving to enjoy time with her community in nature is a way to feed the soul, says columnist.

Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform ...

A combined analysis of data over years in patients in Phase 2 trials of supports benefits for those up to age 65 and moderate ...

The opinion rejects granting conditional marketing authorization to AB Science’s masitinib as an oral add-on treatment for ...

ALS symptom progression brings challenges, but for columnist Dagmar Munn, the key to living well with the disease is to be ...

The first patient has been dosed in an open-label Phase 1/2 clinical trial of AMT-162, uniQure's one-time gene therapy for ...

An ultra-high dose of mecobalamin, a naturally occurring form of vitamin B12, has been approved in Japan under the brand name Rozebalamin to treat amyotrophic lateral sclerosis (ALS). The therapy, ...

The ALS Network – Your connection to care, research, and advocacy. We connect need with support, questions with answers, thought leaders with new ideas, research to funding, and advocates to challenge ...